These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2064258)

  • 1. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
    Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
    Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
    Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular prognosis in Behçet's disease].
    Cochereau-Massin I; Wechsler B; Le Hoang P; Le Thi Huong Du; Girard B; Rousselie F; Godeau P
    J Fr Ophtalmol; 1992; 15(5):343-7. PubMed ID: 1430813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in Behçet's disease resistant to conventional therapy.
    Caspers-Velu LE; Decaux G; Libert J
    Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Behçet's syndrome with colchicine].
    Pacor ML; Nicolis F; Peroli P; Urbani G; Cortina P; Corrocher R; Lunardi C
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):257-61. PubMed ID: 2640046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colchicine in Behcet's disease].
    Haim S; Friedman-Birnbaum R
    Harefuah; 1977 Dec; 93(12):399-400. PubMed ID: 611053
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
    Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment of Behçet's syndrome. Long-term results].
    Martenet AC; Paccolat F
    Ophtalmologie; 1989; 3(1):40-2. PubMed ID: 2641069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation (author's transl)].
    Bonnet M
    J Fr Ophtalmol; 1981; 4(6-7):455-64. PubMed ID: 7299062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
    Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
    Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
    Hayasaka S; Kawamoto K; Noda S; Kodama T
    Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A full thickness macular hole as an uncommon complication of Behçet disease].
    Angioi-Duprez K; Maalouf T; Gérin M; George JL
    J Fr Ophtalmol; 2001 Feb; 24(2):172-4. PubMed ID: 11240490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behcet's disease. Trial treatment with colchicine].
    Bennouna-Biaz F; Heid E; Lazrak B
    Ann Dermatol Venereol; 1982; 109(6-7):593-4. PubMed ID: 7187187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary embolism and Behçet's disease].
    Hammami S; Addad F; Kaoubaa N; Golli M; Chebbi W; Hamzaoui A; Hammami M; Ben Farhat M; Majhoub S
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):786-90. PubMed ID: 17067096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patients with Behçet's disease in the 1980s and 1990s.
    Yoshida A; Kawashima H; Motoyama Y; Shibui H; Kaburaki T; Shimizu K; Ando K; Hijikata K; Izawa Y; Hayashi K; Numaga J; Fujino Y; Masuda K; Araie M
    Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of the ocular form of Behçet disease with cyclosporin A].
    Pahlitzsch T; Wyrobisch W; Kämpe C; Wiederholt M
    Klin Monbl Augenheilkd; 1990 Jun; 196(6):466-9. PubMed ID: 2376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colchicine in the treatment of Behçet's disease (author's transl)].
    Mizushima Y; Matsumura N; Mori M; Matsumura Y; Shimizu T; Fukushima B; Mimura Y; Saito K; Sugiura S; Yamana S; Miyake S; Urayama A; Tanaka Y; Miyoshi K; Shirakami A
    Ryumachi; 1978 Mar; 18(2):112-6. PubMed ID: 663792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation].
    Hamza M; Meddeb S; Mili I; Ouertani A
    Ann Med Interne (Paris); 1992; 143(7):438-41. PubMed ID: 1300863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.